Tillkännagivande • Jun 30
Fujian Kuncai Material Technology Co., Ltd. to Report First Half, 2026 Results on Aug 26, 2026 Fujian Kuncai Material Technology Co., Ltd. announced that they will report first half, 2026 results on Aug 26, 2026 Board Change • May 20
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Taojun Fang was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Tillkännagivande • Apr 23
Fujian Kuncai Material Technology Co., Ltd., Annual General Meeting, May 20, 2026 Fujian Kuncai Material Technology Co., Ltd., Annual General Meeting, May 20, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Fuzhou, Fujian China Tillkännagivande • Mar 30
Fujian Kuncai Material Technology Co., Ltd. to Report Q1, 2026 Results on Apr 23, 2026 Fujian Kuncai Material Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 23, 2026 Tillkännagivande • Dec 26
Fujian Kuncai Material Technology Co., Ltd. to Report Fiscal Year 2025 Results on Apr 23, 2026 Fujian Kuncai Material Technology Co., Ltd. announced that they will report fiscal year 2025 results on Apr 23, 2026 Tillkännagivande • Sep 30
Fujian Kuncai Material Technology Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025 Fujian Kuncai Material Technology Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025 Tillkännagivande • Jun 30
Fujian Kuncai Material Technology Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025 Fujian Kuncai Material Technology Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025 Tillkännagivande • May 13
Fujian Kuncai Material Technology Co., Ltd., Annual General Meeting, Jun 12, 2025 Fujian Kuncai Material Technology Co., Ltd., Annual General Meeting, Jun 12, 2025, at 14:30 China Standard Time. Location: The Company Wholly-owned Subsidiary's Meeting Room, Fuqing, Fujian China Tillkännagivande • Mar 28
Fujian Kuncai Material Technology Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025 Fujian Kuncai Material Technology Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025 Tillkännagivande • Dec 27
Fujian Kuncai Material Technology Co., Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025 Fujian Kuncai Material Technology Co., Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025 New Risk • Nov 14
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 27% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.1x net interest cover). Minor Risk Large one-off items impacting financial results. Reported Earnings • Oct 30
Third quarter 2024 earnings released: EPS: CN¥0.025 (vs CN¥0.042 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.025 (down from CN¥0.042 in 3Q 2023). Revenue: CN¥261.7m (up 23% from 3Q 2023). Net income: CN¥16.2m (down 41% from 3Q 2023). Profit margin: 6.2% (down from 13% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 38% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Tillkännagivande • Sep 30
Fujian Kuncai Material Technology Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Fujian Kuncai Material Technology Co., Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024 New Risk • Aug 19
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 8.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (3.6% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (8.9% average weekly change). Reported Earnings • Aug 10
Second quarter 2024 earnings released: EPS: CN¥0.085 (vs CN¥0.036 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.085. Revenue: CN¥276.9m (up 41% from 2Q 2023). Net income: CN¥23.8m (flat on 2Q 2023). Profit margin: 8.6% (down from 12% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 91% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Tillkännagivande • Jun 29
Fujian Kuncai Material Technology Co., Ltd. to Report First Half, 2024 Results on Aug 10, 2024 Fujian Kuncai Material Technology Co., Ltd. announced that they will report first half, 2024 results on Aug 10, 2024 Tillkännagivande • Apr 27
Fujian Kuncai Material Technology Co., Ltd., Annual General Meeting, May 16, 2024 Fujian Kuncai Material Technology Co., Ltd., Annual General Meeting, May 16, 2024, at 14:30 China Standard Time. Location: The Company Wholly-owned Subsidiary's Meeting Room, Fuqing, Fujian China Reported Earnings • Apr 26
First quarter 2024 earnings released: EPS: CN¥0.043 (vs CN¥0.029 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.043 (up from CN¥0.029 in 1Q 2023). Revenue: CN¥255.0m (up 5.4% from 1Q 2023). Net income: CN¥20.3m (up 51% from 1Q 2023). Profit margin: 8.0% (up from 5.6% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 82% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Reported Earnings • Apr 17
Full year 2023 earnings released: EPS: CN¥0.18 (vs CN¥0.19 in FY 2022) Full year 2023 results: EPS: CN¥0.18 (down from CN¥0.19 in FY 2022). Revenue: CN¥829.0m (up 1.2% from FY 2022). Net income: CN¥83.9m (down 4.6% from FY 2022). Profit margin: 10% (in line with FY 2022). Revenue is forecast to grow 73% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Tillkännagivande • Mar 30
Fujian Kuncai Material Technology Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Fujian Kuncai Material Technology Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024 Tillkännagivande • Dec 29
Fujian Kuncai Material Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024 Fujian Kuncai Material Technology Co., Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024 New Risk • Oct 31
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.2x net interest cover). Minor Risk Large one-off items impacting financial results. Reported Earnings • Oct 26
Third quarter 2023 earnings released: EPS: CN¥0.059 (vs CN¥0.05 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.059 (up from CN¥0.05 in 3Q 2022). Revenue: CN¥212.7m (down 14% from 3Q 2022). Net income: CN¥27.7m (up 19% from 3Q 2022). Profit margin: 13% (up from 9.4% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 67% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Reported Earnings • Aug 26
Second quarter 2023 earnings released: EPS: CN¥0.051 (vs CN¥0.065 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.051 (down from CN¥0.065 in 2Q 2022). Revenue: CN¥196.7m (down 4.9% from 2Q 2022). Net income: CN¥23.9m (down 21% from 2Q 2022). Profit margin: 12% (down from 15% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 50% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Reported Earnings • Apr 29
First quarter 2023 earnings released: EPS: CN¥0.029 (vs CN¥0.057 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.029 (down from CN¥0.057 in 1Q 2022). Revenue: CN¥241.9m (up 22% from 1Q 2022). Net income: CN¥13.5m (down 50% from 1Q 2022). Profit margin: 5.6% (down from 13% in 1Q 2022). The decrease in margin was driven by higher expenses. Board Change • Mar 15
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. 
